dr. naidoo on treating immune-related adverse events in nsclc
Published 6 years ago • 214 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:26
dr. naidoo on managing immune-related adverse events in nsclc
-
1:34
dr. naidoo on the mechanisms behind immune-related adverse events in lung cancer
-
2:35
dr. naidoo discusses the management of immune-related adverse events in lung cancer
-
0:15
copy of dr. naidoo on managing immune-related adverse events in nsclc
-
1:35
dr. naidoo on studies of immune-related adverse events in lung cancer
-
1:25
immune-related adverse events: what to know
-
1:41
dr. naidoo on considerations for managing iraes in nsclc
-
5:21
pd-l1 immune-related adverse events
-
3:32
multisystem immune-related aes with immunotherapy in nsclc
-
1:14
dr. sabari on managing immune-related adverse events in lung cancer
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
0:45
it takes a team: treating adverse events
-
4:10
personal experience with drug-induced ild
-
1:01:40
weekly webinar series part 4: managing lung cancer patients through the covid-19 pandemic
-
4:04
btog 2021 highlights: translational research in lung cancer
-
1:57
managing the adverse events of immune checkpoint inhibitors
-
1:00
dr. naidoo discusses biomarker testing for checkpoint inhibitors
-
1:30
dr. brahmer discusses the management of adverse events from immunotherapy
-
32:14
navigating the complexities of the nsclc treatment pathway: a focus on antibody-drug conjugates